These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1670358)

  • 1. [Why is juvenile-onset diabetes common in Finland?].
    Karjalainen J; Ilonen J; Hyöty H; Leinikki P; Akerblom H
    Duodecim; 1990; 106(9):662-72. PubMed ID: 1670358
    [No Abstract]   [Full Text] [Related]  

  • 2. Complement-mediated cytotoxic effects of islet cell surface antibodies in non-diabetic subjects with antecedent mumps infection and diabetic risk.
    Ratzmann KP; Jahr H; Richter KV
    Exp Clin Endocrinol; 1988 May; 91(2):176-82. PubMed ID: 3044806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic, hormonal, and immunological alterations in subjects with antecedent mumps infection.
    Ratzmann KP; Strese J; Rjasanowski I; Witt S; Kohnert KD; Keilacker H; Richter KV; Giebelmann R; Schulz B
    Exp Clin Endocrinol; 1985 Dec; 86(3):323-34. PubMed ID: 3912201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications of mumps infection, islet-cell antibodies, and HLA.
    Mueller-Eckhardt G; Stief T; Otten A; Helmke K; Willems WR; Mueller-Eckhardt C
    Immunobiology; 1984 Oct; 167(4):338-44. PubMed ID: 6392072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood insulin-dependent diabetes.
    Goto Y; Satoh J
    Adv Exp Med Biol; 1988; 246():215-9. PubMed ID: 3074653
    [No Abstract]   [Full Text] [Related]  

  • 6. Mumps, mumps vaccination, islet cell antibodies and the first manifestation of diabetes mellitus type I.
    Otten A; Helmke K; Stief T; Mueller-Eckhard G; Willems WR; Federlin K
    Behring Inst Mitt; 1984 Jul; (75):83-8. PubMed ID: 6385957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA, autoimmunity, virus and the pathogenesis of juvenile diabetes mellitus.
    Nerup J; Andersen OO; Christy M; Platz P; Ryder L; Thomsen M; Svejgaard A
    Acta Endocrinol Suppl (Copenh); 1976; 205():167-75. PubMed ID: 793277
    [No Abstract]   [Full Text] [Related]  

  • 8. Environmental triggers and determinants of beta-cell autoimmunity and type 1 diabetes.
    Knip M
    Rev Endocr Metab Disord; 2003 Sep; 4(3):213-23. PubMed ID: 14501172
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA-DQB1-defined genetic susceptibility, beta cell autoimmunity, and metabolic characteristics in familial and nonfamilial insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group.
    Veijola R; Reijonen H; Vähäsalo P; Sabbah E; Kulmala P; Ilonen J; Akerblom HK; Knip M
    J Clin Invest; 1996 Dec; 98(11):2489-95. PubMed ID: 8958211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The autoimmune mechanisms of the development of insulin-dependent diabetes mellitus].
    Shishko PI
    Ter Arkh; 1991; 63(6):l46-51. PubMed ID: 1948721
    [No Abstract]   [Full Text] [Related]  

  • 11. Aetiology of insulin-dependent diabetes.
    Leslie RD; Lazarus NR; Vergani D
    Br Med Bull; 1989 Jan; 45(1):58-72. PubMed ID: 2676074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The accelerator hypothesis and increasing incidence of type 1 diabetes.
    Fourlanos S; Harrison LC; Colman PG
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):321-5. PubMed ID: 18594271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mumps infections in the etiology of type 1 (insulin-dependent) diabetes.
    Hyöty H; Leinikki P; Reunanen A; Ilonen J; Surcel HM; Rilva A; Käär ML; Huupponen T; Hakulinen A; Mäkelä AL
    Diabetes Res; 1988 Nov; 9(3):111-6. PubMed ID: 3243043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell reactivity to 38 kD insulin-secretory granule protein in patients with recent onset type 1 diabetes.
    Bonifacio E; Boitard C
    J Endocrinol Invest; 1994; 17(7):559-63. PubMed ID: 7829830
    [No Abstract]   [Full Text] [Related]  

  • 15. Toxic type 1 diabetes.
    Myers MA; Mackay IR; Zimmet PZ
    Rev Endocr Metab Disord; 2003 Sep; 4(3):225-31. PubMed ID: 14501173
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetic lymphocytes transfer and beta cell functions.
    Basabe JC; Fabiano de Bruno LE; Arata M
    Adv Exp Med Biol; 1988; 246():101-7. PubMed ID: 3074644
    [No Abstract]   [Full Text] [Related]  

  • 17. [Slowly progressive IDDM (SPIDDM)].
    Kobayashi T; Kosaka K
    Nihon Rinsho; 1991 Feb; 49 Suppl():412-7. PubMed ID: 2033832
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective immunotherapy of IDDM: a discussion based on new findings from the RIP-LCMV model for autoimmune diabetes.
    von Herrath MG
    Transplant Proc; 1998 Dec; 30(8):4115-21. PubMed ID: 9865317
    [No Abstract]   [Full Text] [Related]  

  • 19. Microbial exposure in infancy and subsequent appearance of type 1 diabetes mellitus-associated autoantibodies: a cohort study.
    Virtanen SM; Takkinen HM; Nwaru BI; Kaila M; Ahonen S; Nevalainen J; Niinistö S; Siljander H; Simell O; Ilonen J; Hyöty H; Veijola R; Knip M
    JAMA Pediatr; 2014 Aug; 168(8):755-63. PubMed ID: 24957949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus infection islet cell antibodies and islet cell function in type I diabetes mellitus.
    Helmke K; Brockhaus R; Seitz M; Otten H; Willems WR; Laube H; Federlin K
    Behring Inst Mitt; 1984 Jul; (75):73-82. PubMed ID: 6385956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.